NP

Nitin Panwar

Active Director Director DIN 09567373
DIN 09567373 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Nitin Panwar

Data last updated:

Nitin Panwar is a Director at Adlec Pharma Private Limited (since 2022). The company operates in Chemicals. Adlec Pharma Private Limited reported revenue of ₹5.3 Lakh (FY 2025).

DIN 09567373
Primary Designation Director
Industry Chemicals
First Appointment 09 Apr 2022
Oldest Company Age 4 yrs
Largest company Adlec Pharma Private Limited · ₹5.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adlec Pharma Private Limited U24230UP2022PTC162162
Director09 Apr 20222022₹5.3 Lakh (FY 2025)Active

Board colleagues of Nitin Panwar

NameDINCompanyDesignation
Pramod09567374Adlec Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Adlec Pharma Private Limited
Premium access

Shareholding and investment profile for Nitin Panwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Panwar

Nitin Panwar currently holds 1 directorship: Adlec Pharma Private Limited (Director, since 09 Apr 2022, revenue ₹5.3 Lakh (FY 2025)).

Nitin Panwar was first appointed on 09 Apr 2022 as Director at Adlec Pharma Private Limited.

The current boards of Nitin Panwar's companies include Pramod (Adlec Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available